X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

INM

Closed

Inmed Pharmaceuticals Inc

3.09
-0.16 (-4.92%)
Last Update: 01 Jul 2025 23:09:00
Yesterday: 3.25
Day's Range: 3. - 3.165
Send
When Written:
 
1.1
InMed Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that is focused on developing cannabinoid-based therapies for various diseases. The company's proprietary drug development platform, known as IntegraSyn, enables the identification and development of novel cannabinoid-based drug candidates. InMed's lead product candidate, INM-755, is currently in clinical trials for the treatment of epidermolysis bullosa, a rare genetic skin disorder. The company is also exploring the potential of its platform in the treatment of other diseases, including glaucoma, pain, and inflammation. InMed Pharmaceuticals is headquartered in Vancouver, Canada, and is listed on the Toronto Stock Exchange and the NASDAQ.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X